Tumor size does indeed matter in the recurrence rate of papillary thyroid carcinoma, according to a new study.
A new study has found that the link between subclinical hypothyroidism and metabolic syndrome is only present in type 2 diabetes.
Low serum estradiol found to have a causal effect on bone mineral density and fracture risk in men vs low testosterone, according to a new study.
Can weight loss alone be the key to the reversal of type 2 diabetes? A new study sheds some light.
Even though my practice partner and I are perfectly fine together and have been for years, I wonder now and then if we should hire. Still wondering.
Growth hormone replacement therapy in adults is effective, but not risk-free. Find out what you know about the good vs not-so-good.
The novel long-acting recombinant human growth hormone may lower number of growth hormone treatments from daily to 2 times per month.
Male thyroid cancer survivors are at a 50% increased risk for developing heart disease vs women, according to one of the first studies of its kind.
Authors of a new study devised a new algorithm that can help physicians identify and manage diabetic patients at increased fracture risk.
How will the newly proposed Centers for Medicare & Medicaid Services fee schedule impact your practice? One physician explains.
Highlights include obstructive sleep apnea as a factor for T2DM; a test that distinguishes between T1DM and T2DM; and missed opportunities in diabetes prevention.
Patients with T2DM who fasted 2 days a week had weight loss and metabolic outcomes similar to patients who followed a daily kcal-restricted diet.
Patients with T2DM and proven cardiovascular disease have elevated markers of inflammation and endothelial stress, according to a new study.
A new study found that left ventricular diastolic function is linked to poor glycemic control and A1c in T2DM patients.
Pituitary dysfunction secondary to traumatic brain injury is receiving increased scrutiny and GHD is the most common isolated deficit. Which test to use?